[go: up one dir, main page]

UA89408C2 - Sustained release solid pharmaceutical composition of 1-(2,3,4-trimethoxybenzyl)piperazine and a method for the preparation thereof - Google Patents

Sustained release solid pharmaceutical composition of 1-(2,3,4-trimethoxybenzyl)piperazine and a method for the preparation thereof

Info

Publication number
UA89408C2
UA89408C2 UAA200714180A UAA200714180A UA89408C2 UA 89408 C2 UA89408 C2 UA 89408C2 UA A200714180 A UAA200714180 A UA A200714180A UA A200714180 A UAA200714180 A UA A200714180A UA 89408 C2 UA89408 C2 UA 89408C2
Authority
UA
Ukraine
Prior art keywords
trimethoxybenzyl
pharmaceutical composition
sustained release
piperazine
solid pharmaceutical
Prior art date
Application number
UAA200714180A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Жером Бессе
Original Assignee
Ле Лаборатуар Сервье
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ле Лаборатуар Сервье filed Critical Ле Лаборатуар Сервье
Publication of UA89408C2 publication Critical patent/UA89408C2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The inventive sustained release solid pharmaceutical composition comprises an 1-(2,3,4-trimethoxybenzyl) piperazine active substance or the pharmaceutically acceptable salt thereof combined with at least one type of polyethylene oxide, at least one type of lubricating agent and one or several pharmaceutically acceptable excipients.
UAA200714180A 2005-05-18 2006-02-13 Sustained release solid pharmaceutical composition of 1-(2,3,4-trimethoxybenzyl)piperazine and a method for the preparation thereof UA89408C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0504997A FR2885807B1 (en) 2005-05-18 2005-05-18 SOLID PHARMACEUTICAL COMPOSITION WITH PROLONGED RELEASE OF 1- (2,3,4-TRIMETHOXYBENZYL) PIPERAZINE, AND PREPARATION METHOD

Publications (1)

Publication Number Publication Date
UA89408C2 true UA89408C2 (en) 2010-01-25

Family

ID=35583424

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200714180A UA89408C2 (en) 2005-05-18 2006-02-13 Sustained release solid pharmaceutical composition of 1-(2,3,4-trimethoxybenzyl)piperazine and a method for the preparation thereof

Country Status (5)

Country Link
EP (1) EP1881831A1 (en)
EA (1) EA013645B1 (en)
FR (1) FR2885807B1 (en)
UA (1) UA89408C2 (en)
WO (1) WO2006123073A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0815602A2 (en) * 2007-08-08 2015-03-03 Usv Ltd PROPOSED TRIMETHYZIDINE RELEASE COMPOSITIONS AND PROCESS FOR PREPARING THEM
EP2200591A2 (en) * 2007-09-11 2010-06-30 Ranbaxy Laboratories Limited Controlled release pharmaceutical dosage forms of trimetazidine
US20110300209A1 (en) * 2009-01-20 2011-12-08 Micro Labs Limited Modified release solid pharmaceutical compositions of trimetazidine and process thereof
TR201001902A2 (en) * 2010-03-12 2011-04-21 Ali̇ Rai̇f İlaç Sanayi̇ Ve Ti̇caret A.Ş. Trimetazidine tablets with extended release
PL2394644T3 (en) * 2010-05-04 2014-11-28 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Trimetazidine Formulation With Different Release Profiles

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2717687B1 (en) * 1994-03-24 1996-06-14 Adir Pharmaceutical compositions for the sustained release of trimetazidine after oral administration.
FR2802424B1 (en) * 1999-12-17 2002-02-15 Adir MATRIX TABLET FOR THE EXTENDED RELEASE OF TRIMETAZIDINE AFTER ORAL ADMINISTRATION
PT1195160E (en) * 2000-10-05 2009-12-07 Usv Ltd Sustained release trimetazidine pharmaceutical compositions and a method of their preparation
FR2818549B1 (en) * 2000-12-26 2003-02-07 Servier Lab SOLID THERMOFORMABLE PHARMACEUTICAL COMPOSITION FOR THE CONTROLLED RELEASE OF TRIMETAZIDINE
AU2002356425A1 (en) * 2001-11-21 2003-06-10 Themis Laboratories Private Limited A process for manufacture of a sustained release composition containing microbe

Also Published As

Publication number Publication date
FR2885807B1 (en) 2008-05-16
EA013645B1 (en) 2010-06-30
FR2885807A1 (en) 2006-11-24
WO2006123073A1 (en) 2006-11-23
EP1881831A1 (en) 2008-01-30
EA200702386A1 (en) 2008-04-28

Similar Documents

Publication Publication Date Title
WO2006015943A3 (en) Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof
EP1589947B8 (en) Pharmaceutical formulation with an insoluble active agent for pulmonary administration
WO2007008752A3 (en) Sustained release pharmaceutical compositions for highly water soluble drugs
TNSN07304A1 (en) Combination of xolair with immunosuppressive agent
EA200901393A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING GESTAGENES AND / OR ESTROGENS AND 5 METHYL- (6S) -TETRAHYDROPHOLATE
BG108516A (en) Pharmaceutical formulation
HK1045113A1 (en) Oral administration form for administering a fixed tramadol and diclofenac combination
PT1121127E (en) PHARMACEUTICAL COMPOSITIONS ORAIS CONTAINING BUPRENORFIN
ZA200603538B (en) P-glycoprotein inhibitor, method for preparing the same and pharmaceutical composition comprising the same
TW200609005A (en) Film-coated tablet with plural coating-layers
WO2005007137A3 (en) Tablets containing ambroxol
WO2007100382A3 (en) Orally administrable gallium compositions and method of use
MXPA03008420A (en) Solid orally-dispersible pharmaceutical formulation.
BR0112847A (en) Use of a solid dosage form
EP3949967A8 (en) Solid pharmaceutical composition comprising tlr7 agonist
ZA200709296B (en) Ophthalmic suspension comprising an ophthalmic drug, a poloxamine and a glycolotonicity-adjusting agent, use of said composition for the manufacture of a medicament for treating ophthalmic disorders
UA89408C2 (en) Sustained release solid pharmaceutical composition of 1-(2,3,4-trimethoxybenzyl)piperazine and a method for the preparation thereof
TR200604349A2 (en) Pharmaceutical compositions containing aripiprazole
TW200509980A (en) Parasiticidal composition
WO2007121471A3 (en) Dialkyl ether delivery agents
JP2006527741A5 (en)
CA2473718A1 (en) Immediate-release pharmaceutical dosage form comprising polymorphous tibolone
GR1004331B (en) New pharmaceutical compositions that contain a salt of alendronic acid.
TW200621304A (en) Pharmaceutical composition
MY158344A (en) Oral drug delivery system